Sr. Scientist (R2-R3)

Sr. Scientist (R2-R3) – Lilly Responsibilities Provide technical support for the manufacturing of Active Pharmaceutical Ingredients (APIs). Support technology transfer and process validation of manufacturing processes in external manufacturing areas. Execute technical projects to improve and optimize process control, yield, purity, and productivity. Perform process monitoring on manufacturing data to assess variability and identify improvement opportunities. Author and review technical documents translating process knowledge and control strategies into manufacturing documentation. Serve as frontline technical services and active member of process teams to achieve project and manufacturing goals. Qualifications Bachelor’s degree in Chemical Engineering, Biochemistry, Physical Chemistry or related STEM field. Minimum 3 years of cGMP API manufacturing experience from TS/MS or Development organization. 3 years of experience in small molecule API manufacturing. 2 years of experience in process scale‑up, pilot plant pharmaceutical manufacturing, technology transfer of small molecule synthetic drug substance, process validation and data monitoring. 1 year of experience in root cause analysis investigation at cGMP setting. Up to 20% domestic and international travel required. Location Indianapolis, IN. Compensation and Benefits Salary range: $99,424.00 – $117,763.00 per year. Full‑time employees are eligible for a company bonus depending on performance and a comprehensive benefits program including 401(k) match, pension, vacation, medical, dental, vision and prescription drug coverage, flexible spending accounts, life insurance, disability, leave of absence, employee assistance program, fitness and employee clubs and activities. EEO Statement Lilly is a proud EEO Employer and does not discriminate on the basis of age, race, color, religion, gender identity, sex, gender expression, sexual orientation, genetic information, ancestry, national origin, protected veteran status, disability, or any other legally protected status. #J-18808-Ljbffr Initial Therapeutics, Inc.